Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person